We are live on
!
Find out more
TC
Tejara Capital Portfolio holdings
AUM
$303M
1-Year Est. Return
5.43%
This Fund
S&P 500
This Quarter
Est. Return
+14.5%
1 Year Est. Return
+5.43%
3 Year Est. Return
+13.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$272M
AUM Growth
+$33.4M
(+14%)
Cap. Flow
+$12.4M
Cap. Flow
% of AUM
4.55%
Top 10 Holdings %
Top 10 Hldgs %
48.68%
Holding
93
New
26
Increased
22
Reduced
22
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Scorpio Tankers
STNG
|
+$11.8M |
| 2 |
Rekor Systems
REKR
|
+$5.04M |
| 3 |
Roivant Sciences
ROIV
|
+$5.02M |
| 4 |
QuidelOrtho
QDEL
|
+$4.08M |
| 5 |
iShares Silver Trust
SLV
|
+$3.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$9.57M |
| 2 |
Citigroup
C
|
+$7.9M |
| 3 |
Freeport-McMoran
FCX
|
+$5.18M |
| 4 |
Collegium Pharmaceutical
COLL
|
+$4.34M |
| 5 |
MREO
Mereo BioPharma
MREO
|
+$4.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.56% |
| 2 | Energy | 35.34% |
| 3 | Technology | 5.46% |
| 4 | Industrials | 4.42% |
| 5 | Financials | 3.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
FTAI Infrastructure
FIP
$447M
| $967K | 0.36% |
153,985
+119,432
| +346% | +$554K |
|
52
TherapeuticsMD
TXMD
$23.8M
| $920K | 0.34% |
401,937
| – | – |
|
53
Valaris
VAL
$5.14B
| $902K | 0.33% |
+11,991
| New | +$804K |
|
54
Adaptive Biotechnologies
ADPT
$3.61B
| $864K | 0.32% |
+269,014
| New | +$1.04M |
|
55
Kiniksa Pharmaceuticals
KNSA
$6.23B
| $841K | 0.31% |
42,649
-52,500
| -55% | -$1.03M |
|
|
CNR
56
Core Natural Resources Inc
CNR
$3.93B
| $838K | 0.31% |
10,000
-11,831
| -54% | -$1.06M |
|
|
RVNC
57
DELISTED
Revance Therapeutics, Inc.
RVNC
| $836K | 0.31% |
+170,000
| New | +$1.01M |
|
58
TORM
TRMD
$3.05B
| $800K | 0.29% |
22,900
+2,900
| +15% | +$98.6K |
|
59
PUT
Invesco QQQ Trust
QQQ
$436B
| $779K | 0.29% |
+2,900
| New | +$1.24M |
|
60
Constellium
CSTM
$3.76B
| $663K | 0.24% |
+30,000
| New | +$581K |
|
61
Pacira BioSciences
PCRX
$1.04B
| $584K | 0.21% |
+20,000
| New | +$614K |
|
62
Dole
DOLE
$1.38B
| $529K | 0.19% |
44,314
-8,650
| -16% | -$100K |
|
63
AtaiBeckley Inc
ATAI
$2.66B
| $513K | 0.19% |
260,215
-30,000
| -10% | -$55.2K |
|
64
Oportun Financial
OPRT
$262M
| $439K | 0.16% |
180,827
-285,493
| -61% | -$1.03M |
|
|
CMRX
65
DELISTED
Chimerix, Inc.
CMRX
| $439K | 0.16% |
414,430
-135,646
| -25% | -$141K |
|
|
RNLX
66
DELISTED
Renalytix plc American Depositary Shares
RNLX
| $430K | 0.16% |
500,394
+100,000
| +25% | +$68.5K |
|
67
ZIM Integrated Shipping Services
ZIM
$2.96B
| $415K | 0.15% |
+40,986
| New | +$498K |
|
|
PTVE
68
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $406K | 0.15% |
+28,343
| New | +$402K |
|
|
ICD
69
DELISTED
Independence Contract Drilling, Inc.
ICD
| $370K | 0.14% |
198,950
-335,994
| -63% | -$658K |
|
70
Precision BioSciences
DTIL
$178M
| $336K | 0.12% |
24,767
| – | – |
|
71
Ovid Therapeutics
OVID
$427M
| $223K | 0.08% |
73,153
| – | – |
|
|
72
CALL
Scorpio Tankers
STNG
$3.91B
| $190K | 0.07% |
+500
| New | +$33.9K |
|
73
Trevi Therapeutics
TRVI
$2.57B
| $129K | 0.05% |
37,481
-1,231,519
| -97% | -$2.75M |
|
74
Genesis Energy
GEL
$1.82B
| $25.8K | 0.01% |
+184,384
| New | +$2.11M |
|
|
AXDX
75
DELISTED
Accelerate Diagnostics
AXDX
| $13.5K | 0.01% |
13,614
| – | – |
|
Similar funds
EC
ECAM
BPH
BCC
BKA
AFO
OWM
WAOTB
Tejara Capital's Q1 2024 Portfolio in Review
As of Q1 2024, Tejara Capital held 93 positions worth $272M, up 14% from $239M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Tejara Capital deployed $12.4M of net new capital in Q1 2024, opening 26 new positions and adding to 22 existing holdings. Its largest new stake was QuidelOrtho: 70,000 shares worth $3.36M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 38% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was Mereo BioPharma, an estimated $4.21M trimmed.
- Tejara Capital's largest Q1 2024 buy was QuidelOrtho: 70,000 shares worth $3.36M.
- Tejara Capital added most to Scorpio Tankers in Q1 2024, an estimated $11.8M increase.
- Tejara Capital's biggest Q1 2024 reduction was Mereo BioPharma, cutting an estimated $4.21M.
- Tejara Capital fully exited Newmont in Q1 2024, selling an estimated $9.57M.
- Tejara Capital's ten largest holdings make up 49% of its $272M portfolio in Q1 2024.
- Tejara Capital opened 26 new positions and closed 18 in Q1 2024.
- Tejara Capital's portfolio value rose 14% quarter-over-quarter to $272M.
Based on Tejara Capital's 13F filing for Q1 2024, filed 14 May 2024.